These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2538111)

  • 21. Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1.
    Tewari D; Gibson JS; Slater JD; O'Neill T; Hannant D; Allen GP; Field HJ
    Arch Virol; 1993; 132(1-2):101-20. PubMed ID: 8394686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins.
    Cook RF; O'Neill T; Strachan E; Sundquist B; Mumford JA
    Vaccine; 1990 Oct; 8(5):491-6. PubMed ID: 2174599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of glycoprotein gp1 of bovine herpesvirus type 4.
    Dubuisson J; Pastoret PP; Thiry E
    J Gen Virol; 1992 May; 73 ( Pt 5)():1293-6. PubMed ID: 1316948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The characterization of equine herpes virus-1-infected cell polypeptides recognized by equine lymphocytes.
    Bridges CG; Ledger N; Edington N
    Immunology; 1988 Feb; 63(2):193-8. PubMed ID: 2832309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and characterization of monoclonal antibodies to bovid herpesvirus-4.
    Dubuisson J; Thiry E; Bublot M; Sneyers M; Boulanger D; Guillaume J; Pastoret PP
    Vet Microbiol; 1989 Apr; 19(4):305-15. PubMed ID: 2546320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycoprotein-specific immune responses in cats after exposure to feline herpesvirus-1.
    Burgener DC; Maes RK
    Am J Vet Res; 1988 Oct; 49(10):1673-6. PubMed ID: 2847603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunological relationship between canine herpesvirus and four other herpesviruses.
    Manning A; Buchan A; Skinner GR; Durham J; Thompson H
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1601-8. PubMed ID: 2839597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S
    Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model.
    Stokes A; Corteyn AH; Pullen LA; Doel TR; Meredith DM; Killington RA; Halliburton IW; Whittaker GR; Wheldon LA; Nicolson L
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():923-31. PubMed ID: 1707948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A monoclonal antibody to inclusion body disease of cranes virus enabling specific immunohistochemistry and competitive ELISA.
    Letchworth GJ; Fishel JR; Hansen W
    Avian Dis; 1997; 41(4):808-16. PubMed ID: 9454913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
    Wilks CR; Coggins L
    Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD; Henry JN; McKnight JD
    Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD; Marron AE; Bass EP; Beckenhauer WH
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective antigens of equine herpesvirus type 1.
    Papp-Vid G; Derbyshire JB
    Can J Comp Med; 1978 Apr; 42(2):219-26. PubMed ID: 208736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equine herpesvirus.
    Vet Rec; 1989 May; 124(19):519. PubMed ID: 2547266
    [No Abstract]   [Full Text] [Related]  

  • 38. Towards a vaccine against equine herpesvirus 1.
    Sabine M; Whalley JM
    Aust Vet J; 1989 Dec; 66(12):403-4. PubMed ID: 2559691
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on cross-reactive antigens in the herpesviruses.
    Yeo J; Killington RA; Watson DH; Powell KL
    Virology; 1981 Jan; 108(2):256-66. PubMed ID: 6162270
    [No Abstract]   [Full Text] [Related]  

  • 40. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA; Bates J
    Vet Rec; 1984 Apr; 114(15):375-81. PubMed ID: 6328729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.